JP2004217639A - アルツハイマー病治療剤 - Google Patents
アルツハイマー病治療剤 Download PDFInfo
- Publication number
- JP2004217639A JP2004217639A JP2003424981A JP2003424981A JP2004217639A JP 2004217639 A JP2004217639 A JP 2004217639A JP 2003424981 A JP2003424981 A JP 2003424981A JP 2003424981 A JP2003424981 A JP 2003424981A JP 2004217639 A JP2004217639 A JP 2004217639A
- Authority
- JP
- Japan
- Prior art keywords
- present
- administration
- treating agent
- sdat
- dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 Oc(cc(c(CC1CC2CC*(CC3CCCCC3)CC2)c2)C1=O)c2[O+] Chemical compound Oc(cc(c(CC1CC2CC*(CC3CCCCC3)CC2)c2)C1=O)c2[O+] 0.000 description 1
Images
Landscapes
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
ドネペジル化合物はアセチルコリンエステラーゼ阻害活性を有し、脳内の神経伝達物質としてのアセチルコリンを増量させて、脳のコリン作動性機能低下を防止する効果を有するものである。
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003424981A JP2004217639A (ja) | 2002-12-24 | 2003-12-22 | アルツハイマー病治療剤 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002372984 | 2002-12-24 | ||
JP2003424981A JP2004217639A (ja) | 2002-12-24 | 2003-12-22 | アルツハイマー病治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004217639A true JP2004217639A (ja) | 2004-08-05 |
Family
ID=32911032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003424981A Pending JP2004217639A (ja) | 2002-12-24 | 2003-12-22 | アルツハイマー病治療剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2004217639A (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009524599A (ja) * | 2006-01-04 | 2009-07-02 | シプラ・リミテッド | ドネペジルを調製するための方法および中間体 |
-
2003
- 2003-12-22 JP JP2003424981A patent/JP2004217639A/ja active Pending
Non-Patent Citations (1)
Title |
---|
JPN6010004131, Journal of Clinical Rehabilitation, 200207, Vol.11, No.7, pp.630−634 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009524599A (ja) * | 2006-01-04 | 2009-07-02 | シプラ・リミテッド | ドネペジルを調製するための方法および中間体 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200345680A1 (en) | Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep | |
US6335021B1 (en) | Composition for controlling mood disorders in healthy individuals | |
RU2403039C2 (ru) | Лечение биполярных расстройств и сопутствующих симптомов | |
JP2006506378A5 (ja) | ||
US20170304351A1 (en) | Combination therapy for the treatment of depression and other non-infectious diseases | |
US20090042972A1 (en) | Methods of using low-dose doxepin for the improvement of sleep | |
US20090042971A1 (en) | Method of using low-dose doxepin for the improvement of sleep | |
US20050203124A1 (en) | Compounds for the sustained reduction of body weight | |
JP2004189706A (ja) | 高度アルツハイマー型痴呆治療剤 | |
JPH0761923A (ja) | アルツハイマー病治療剤 | |
EP1292305B1 (en) | Use of l-threo methylphenidate for the manufacture of a medicament for the treatment of psychotic disorders | |
EP0808626A1 (en) | Use of acetyl-L-carnitine for the treatment of presenile Alzheimer's disease | |
MXPA97003810A (en) | A medicine that comprises a carnitin derivative to treat alzheimer's disease in patients with premat start | |
JP2011506353A (ja) | セロトニントランスポーター、セロトニン受容体およびノルアドレナリントランスポーターに親和性を有する化合物の治療的使用 | |
JP2004217639A (ja) | アルツハイマー病治療剤 | |
US20050137222A1 (en) | Treatment of insomnia in human patients | |
JP5299949B2 (ja) | シロスタゾールの統合失調症治療剤 | |
JP6025886B2 (ja) | 慢性疼痛治療剤 | |
CA2330568A1 (en) | Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders | |
US11523984B1 (en) | Compositions and methods of administering baclofen | |
US20240197698A1 (en) | Treatment of acute anxiety with an alpha-7 nicotinic acetylcholine receptor modulator | |
WO2021146425A1 (en) | Methods of treating acute muscle spasms | |
US20070054940A1 (en) | Remedy for down's syndrome | |
US20230381169A1 (en) | Treatment of public speaking anxiety with an alpha-7 nicotinic acetylcholine receptor agonist | |
JP2024508372A (ja) | 注意欠陥/多動性障害の治療又は予防に使用するための化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20060829 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060912 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061003 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061011 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100201 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100608 |